JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Scope & Guideline

Unveiling the Mechanisms of the Renin-Angiotensin-Aldosterone System

Introduction

Delve into the academic richness of JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1470-3203
PublisherSAGE PUBLICATIONS INC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2000 to 2023
AbbreviationJ RENIN-ANGIO-ALDO S / J. Renin-Angiotensin-Aldosterone Syst.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2455 TELLER RD, THOUSAND OAKS, CA 91320

Aims and Scopes

The JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM focuses on the multifaceted roles of the renin-angiotensin-aldosterone system (RAAS) in various physiological and pathological conditions. It aims to publish high-quality research that advances our understanding of the RAAS and its implications in health and disease.
  1. Pathophysiology of the Renin-Angiotensin-Aldosterone System (RAAS):
    The journal emphasizes studies exploring the mechanisms by which RAAS components influence cardiovascular, renal, and metabolic diseases, contributing to the understanding of their roles in health and disease.
  2. Genetic and Molecular Studies:
    Research focusing on genetic polymorphisms and molecular pathways related to RAAS is a key area, providing insights into individual variations in disease susceptibility and treatment responses.
  3. Clinical Applications and Therapeutic Interventions:
    The journal publishes clinical studies that evaluate the effectiveness of RAAS-targeting therapies in treating conditions like hypertension, heart failure, and acute kidney injury, thereby bridging laboratory research and clinical practice.
  4. Emerging Diseases and RAAS Interactions:
    The journal addresses the role of the RAAS in emerging diseases, such as COVID-19, highlighting its relevance in contemporary health challenges.
  5. Innovative Therapeutic Strategies:
    Research on new pharmacological interventions and their effects on the RAAS, including studies on novel drug mechanisms and their potential to mitigate disease progression.
Recent publications in the JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM have shown a notable shift towards several emerging themes that highlight the evolving landscape of research related to the RAAS. These trends reflect current health challenges and advancements in understanding RAAS functions.
  1. Impact of RAAS in COVID-19:
    A significant increase in studies examining the relationship between RAAS and COVID-19 has emerged, emphasizing the system's role in the pathophysiology of the disease and potential therapeutic implications.
  2. Inflammation and RAAS Interactions:
    There is a growing interest in the inflammatory aspects of RAAS, particularly how it contributes to conditions like acute kidney injury and cardiovascular diseases, illustrating a trend towards understanding the interplay between these pathways.
  3. Personalized Medicine Approaches:
    Research focusing on genetic variants and their implications for personalized treatment strategies in RAAS-related diseases is gaining traction, indicating a shift towards tailored therapeutic interventions based on individual genetic profiles.
  4. Role of RAAS in Metabolic Disorders:
    Emerging studies are increasingly exploring the intersection of RAAS and metabolic disorders, such as diabetes and obesity, highlighting its relevance in a broader spectrum of health issues.
  5. Novel Pharmacological Interventions:
    There is an upward trend in research investigating new drugs targeting RAAS components and their mechanisms, showcasing the journal's commitment to advancing therapeutic options.

Declining or Waning

While the JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM continues to grow in several key areas, certain themes have seen a decline in recent publications. These topics, once prominent, are now less frequently explored or have shifted in focus.
  1. Basic Science Research on RAAS Components:
    There appears to be a waning interest in purely basic science studies focused solely on isolated RAAS components, as the journal increasingly emphasizes translational and clinical research that ties basic findings to therapeutic applications.
  2. Non-Cardiovascular Applications:
    Research exploring the role of RAAS in non-cardiovascular contexts, such as its effects on gastrointestinal or reproductive systems, has become less common, reflecting a narrowing focus on cardiovascular and renal applications.
  3. Longitudinal Studies in General Populations:
    The frequency of large-scale longitudinal studies examining the long-term effects of RAAS on diverse populations has declined, possibly due to a shift towards more specific and controlled clinical trials.

Similar Journals

JCI Insight

Unlocking Knowledge, Inspiring Change
Publisher: AMER SOC CLINICAL INVESTIGATION INCISSN: Frequency: 24 issues/year

JCI Insight, published by the American Society for Clinical Investigation, stands as a vital resource in the field of medicine, having achieved a prestigious Q1 rating in the 2023 category for miscellaneous medicine. With an impressive Scopus rank of 27 out of 636, placing it in the 95th percentile, this journal emphasizes the dissemination of high-quality, peer-reviewed research that pushes the boundaries of clinical and translational science. Since becoming an Open Access journal in 2020, JCI Insight has expanded its reach, providing researchers, professionals, and students around the globe with unfettered access to groundbreaking studies and reviews. The journal focuses on a wide spectrum of topics relevant to the medical community, making it an essential platform for sharing innovative findings and fostering collaboration among scientists dedicated to transforming health outcomes. Based in Ann Arbor, Michigan, JCI Insight continues to inspire advancements in medical research, contributing significantly to the ongoing dialogue in the ever-evolving healthcare landscape.

ENDOCRINE RESEARCH

Pioneering discoveries in endocrine health.
Publisher: TAYLOR & FRANCIS INCISSN: 0743-5800Frequency: 4 issues/year

ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.

European Journal of Internal Medicine

Fostering Innovation in Patient Care and Treatment
Publisher: ELSEVIERISSN: 0953-6205Frequency: 10 issues/year

The European Journal of Internal Medicine is a leading academic publication dedicated to advancing the field of internal medicine, published by ELSEVIER from the Netherlands. With an impressive impact factor and a Q1 ranking in the Internal Medicine category, this journal stands out as a vital resource for researchers, healthcare professionals, and students alike. Spanning over three decades of converged publications from 1989 to 2024, it features high-quality peer-reviewed articles that cover a wide array of topics pertinent to clinical practice and medical research. Recognized for its contribution to the field, it occupies the notable 22nd position among 167 in Scopus rankings, reflecting its influential role in shaping contemporary medical discourse. The European Journal of Internal Medicine is not only a hub for innovative findings but also serves as a platform for interdisciplinary collaboration, offering valuable insights that foster advancements in patient care and treatment methodologies.

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Innovating Clinical Insights for Better Patient Outcomes
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5484Frequency: 1 issue/year

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

Arterial Hypertension

Advancing cardiovascular health through open dialogue.
Publisher: VIA MEDICAISSN: 2449-6170Frequency: 4 issues/year

Arterial Hypertension is a dedicated Open Access journal published by VIA MEDICA, with the ISSN 2449-6170 and E-ISSN 2449-6162, focusing on the multidisciplinary field of cardiology, endocrinology, and internal medicine. Established in Poland, this journal has been providing researchers and healthcare professionals with accessible, high-quality content since its inception in 1999. With a commitment to advancing knowledge in the management and treatment of arterial hypertension, it publishes significant research findings, clinical trials, and reviews that contribute to improved health outcomes. Though classified in Q4 across various relevant categories, the continuous improvement in its content ensures its relevance in an evolving medical landscape. Designed to facilitate collaboration and innovation, Arterial Hypertension serves as a crucial resource for anyone invested in cardiovascular health, encouraging open dialogue and dissemination of vital research within the scientific community.

CLINICAL SCIENCE

Connecting Science and Practice for Enhanced Healthcare
Publisher: PORTLAND PRESS LTDISSN: 0143-5221Frequency: 24 issues/year

CLINICAL SCIENCE, published by PORTLAND PRESS LTD, is a prestigious journal with an established history that dates back to 1946. Renowned for its rigorous peer-reviewed articles, the journal is dedicated to advancing knowledge in the field of medicine, particularly in the nuances of clinical science and translational research. With an impressive Q1 ranking in the **Medicine (miscellaneous)** category and a Scopus rank of #32 out of 636 in general medicine, it is firmly positioned in the top 5% percentile of its field, making it an essential resource for researchers, practitioners, and students aiming to stay at the forefront of the discipline. Although the journal operates on a traditional subscription model, its influence and accessibility ensure that critical findings and innovative methodologies reach a wide audience, fostering collaboration and progress within the global medical community. The journal seeks to publish groundbreaking studies, critical reviews, and insights that can translate into improved clinical practices, thus reinforcing its mission to enhance patient care and medical knowledge.

Journal of the Saudi Heart Association

Uniting Global Expertise in Heart Disease Management
Publisher: DIGITAL COMMONS BEPRESSISSN: 1016-7315Frequency: 4 issues/year

The Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.

KOREAN JOURNAL OF INTERNAL MEDICINE

Connecting Researchers and Practitioners in Internal Medicine
Publisher: KOREAN ASSOC INTERNAL MEDICINEISSN: 1226-3303Frequency: 6 issues/year

Korean Journal of Internal Medicine, ISSN 1226-3303, E-ISSN 2005-6648, published by the Korean Association of Internal Medicine, stands as a vital resource in the field of internal medicine. Since its inception in 1961 and the shift to open access in 1986, this journal has consistently provided a platform for innovative research and clinical practices, contributing significantly to the advancement of medical knowledge in South Korea and beyond. With an impressive 2023 impact factor and a Q2 quartile ranking among internal medicine journals, it occupies a commendable position in Scopus rankings, holding the #54 slot out of 167 in the category. The journal emphasizes the dissemination of high-quality research findings, clinical reviews, and case reports, making it indispensable for researchers, professionals, and students eager to stay at the forefront of internal medicine. For authors and readers alike, the journal fosters an engaged and informed community, supporting the continuing education and professional development necessary in today's rapidly evolving medical landscape.

METABOLISM-CLINICAL AND EXPERIMENTAL

Pioneering Research in Endocrinology and Diabetes
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0026-0495Frequency: 12 issues/year

METABOLISM-CLINICAL AND EXPERIMENTAL is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, with a distinguished history dating back to 1952. This journal serves as a vital repository of knowledge in the fields of Endocrinology, Diabetes, and Metabolism, consistently ranking in the top quartile (Q1) within these categories according to the latest metrics. With an impressive impact factor and recognized for its contributions to Biochemistry, Genetics, and Molecular Biology, it ranks #5 out of 128 in the Scopus database for Endocrinology and #11 out of 244 for Medicine related to Endocrinology, Diabetes, and Metabolism, placing it in the 95th and 96th percentiles, respectively. While the journal does not currently offer open access, it maintains rigorous peer review standards and publishes cutting-edge research that drives forward the understanding of metabolic diseases and clinical practices. By engaging with METABOLISM-CLINICAL AND EXPERIMENTAL, researchers, healthcare professionals, and students can explore groundbreaking advancements and pivotal findings that shape the future of metabolic health.

Monaldi Archives for Chest Disease

Fostering Global Dialogue in Cardiology and Pulmonology
Publisher: PAGEPRESS PUBLISSN: 1122-0643Frequency: 3 issues/year

The Monaldi Archives for Chest Disease, published by PAGEPRESS PUBL, is a vital resource for researchers and healthcare professionals dedicated to the fields of cardiology and pulmonary medicine. With an ISSN of 1122-0643 and an E-ISSN of 2532-5264, this Open Access journal has been committed to disseminating high-quality research since 2004, ensuring that findings in chest disease are easily accessible to a global audience. Based in Italy, the journal features contributions that reflect a broad scope of topics within its fields, achieving a Q3 ranking in both Cardiology and Cardiovascular Medicine, as well as in Pulmonary and Respiratory Medicine as of 2023. The journal's Scopus ranks place it at 168th out of 387 in its cardiology category and 83rd out of 155 in pulmonary medicine, indicating its relevance in the academic landscape. With its commitment to advancing knowledge and practice, the Monaldi Archives for Chest Disease stands as an essential platform for publication and dialogue in chest disease research, appealing to a diverse audience of scholars and practitioners.